Posts

Showing posts with the label direct-to-consumer

Consumer Neurotechnology: New Products, More Regulatory Complexity

Image
By Anna Wexler Anna Wexler is a PhD candidate in the HASTS (History, Anthropology, Science, Technology and Society) at MIT and a 2015-2016 visiting scholar at the Center for Neuroscience and Society at the University of Pennsylvania. Her dissertation focuses on the ethical, legal and social implications of emerging neuroscience technology, with a particular focus on the home use of noninvasive brain stimulation. Just when it seemed like the consumer neurotechnology market couldn’t get any stranger—after all, who would’ve expected that a sleek white triangle could be placed on the forehead for “calm” or “energy” vibes—two new products recently hit the market that further complicate the challenges of regulating this emerging market. Halo Sport is a brain stimulator marketed for athletic enhancement that utilizes technology similar to transcranial direct current stimulation (tDCS), while Nervana , which began taking pre-orders in March, is the first noninvasive vagus nerve stimulation ...

23andMe: The Ethics of Genetic Testing for Neurodegenerative Diseases

Image
by Liana Meffert The following post is part of a special series emerging from Contemporary Issues in Neuroethics, a graduate-level course out of Emory University’s Center for Ethics. Liana is a senior at Emory University majoring in Neuroscience and Behavioral Biology and Creative Writing (poetry). She is currently applying to Public Health graduate schools and considering a future in medicine. In her free time she enjoys running, reading, and her research on PTSD at Grady Memorial Hospital. 23andMe logo   The face of genetic testing and counseling is in the midst of a major overhaul. Historically, a patient had to demonstrate several risk factors including familial and medical health history or early symptoms in order to be tested for the likelihood of developing a neurodegenerative disease. For the first time, the public has unrestricted and unregulated access to the relative probability of developing certain neurodegenerative diseases. So why is finding out you may devel...

Hot off the presses! Ethical issues with direct-to-consumer neuroscience

Image
Ethical issues with Lumosity and other Direct-to-Consumer Brain Training Games by Emory Neuroethics Program Director and AJOB Neuroscience Editor-in-Residence, Dr. Karen Rommelfanger and AJOB Neuroscience editorial intern Ryan Purcell. Article is open access here for the next 50 days until June 11, 2015. "Internet brain training programs, where consumers serve as both subjects and funders of the research, represent the closest engagement many individuals have with neuroscience. Safeguards are needed to protect participants’ privacy and the evolving scientific enterprise of big data."